Usage Information
Citation Information: J Clin Invest. 1981;67(6):1703-1711. https://doi.org/10.1172/JCI110208.
Selectivity of Dobutamine for Adrenergic Receptor Subtypes: IN VITRO ANALYSIS BY RADIOLIGAND BINDING
Abstract
The cardiovascular responses elicited by dobutamine are distinctly different from those produced by other adrenergic or dopaminergic agonists. To test the hypothesis that dobutamine could have differential affinities for adrenergic receptor subtypes, and that such subtype selectivity could be related to its relatively unique pharmacologic properties, we assessed the ability of dobutamine to displace adrenergic radioligands from membrane receptors in a number of tissues of previously characterized adrenergic receptor subtype. For beta adrenergic receptors identified by (−) [3H]dihydroalprenolol (DHA), dobutamine had significantly greater affinity for the β1 subtype (KD = 2.5 μM in rat heart and 2.6 μM in turkey erythrocyte) than for the β2 subtype (KD = 14.8 μM in frog heart and 25.4 μM in rat lung) (P < 0.001). For alpha adrenergic receptors, dobutamine had markedly greater affinity for the α1-subtype identified by [3H]prazosin (KD = 0.09 μM in rat heart and 0.14 μM in rabbit uterus) than for the α2-subtype identified by [3H]dihydroergocryptine (DHE) (KD = 9.3 μM in human platelet) or by [3H]yohimbine (KD = 5.7 μM in rabbit uterus) (P < 0.001).
Authors
R. Sanders Williams, Timothy Bishop
Usage data is cumulative from May 2024 through May 2025.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 242 | 100 |
| 53 | 28 | |
| Scanned page | 342 | 23 |
| Citation downloads | 59 | 0 |
| Totals | 696 | 151 |
| Total Views | 847 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)